OPKOPKO Health, Inc.
$1.38-4.8% 1Y
$1.38
$1.1052 weeks$1.73
The financials
OPKO Health, Inc. by the numbers
OPKO Health, Inc. (OPK) reported revenue of $164M in Q2 2026 (quarter ended Jun 30, 2026), up 4.3% from the same quarter a year earlier. That came with a gross margin of 49% and net loss of $8.4M. For the full year FY2025, revenue was $607M (−15% year on year) and net income −$226M. Its largest product in Q2 2026 was Service at $75M, 40% of the disclosed total, ahead of Intellectual Property And Other at 25%. The next results filing is expected around Oct 28, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $164M | $157M | +4.3% |
| Gross profit | $80M | $49M | +62% |
| Operating income | −$7.0M | −$60M | n/a |
| Net income | −$8.4M | −$148M | n/a |
| Diluted EPS | −$0.01 | −$0.19 | n/a |
| Product | Revenue | Share |
|---|---|---|
| Service | $75M | 40% |
| Intellectual Property And Other | $46M | 25% |
| Transfer Of Intellectual Property And Other | $46M | 25% |
| Rayaldee | $14M | 7.6% |
| Royalty | $6.4M | 3.4% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $187.4M (+66%)
Transfer Of Intellectual Property And Other grew +208% year on yearService -26% year on year
Segment Latestquarter on quarteryear on year
- Service$74.5M$74.5Mquarter on quarter +3.3%year on year -26%+3.3%-26%
- Intellectual Property And Other$46.1M$46.1Mquarter on quarter +229%year on year +207%+229%+207%
- Transfer Of Intellectual Property And Other$46.1M$46.1Mquarter on quarter +230%year on year +208%+230%+208%
- Rayaldee$14.3M$14.3Mquarter on quarter +11%year on year -1.8%+11%-1.8%
- Royalty$6.4M$6.4Mquarter on quarter n/ayear on year +4.9%n/a+4.9%
On our screens:Stocks with no debt
Diagnostics & Research
Ranks #19 of 21 by RyuScore